• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Asthma Prophylactics
    14 Drugs classified under this therapeutic system

    All the Therapeutic System Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    partial basket chart

    Monoclonal Antibody. Reslizumab 10 mg/ml.
    VIAL(Concent. for sol.  for infus.): 1×10ml, 100ml. IV infus. only. Do not admin. as an IV push or bolus. The recomm. regimen is 3 mg/kg once every 4 wks. admin. by IV infus. over 20-50 min. Discont. the infus. immed. if the pt. experience. a sev. syst.  react., including anaphylaxis.
    Indic. for the add-on mainten. tmt. of pts. with sev. asthma aged 18 yrs. and older with an eosinophilic phenotype.
    C/I: Hypersens.

    Flixotide Nebules
    partial basket chart
    Flixotide Nebules

    Corticosteroid. Fluticasone Propionate 0.5 mg / 2 ml, 2 mg/ 2 ml.
    AMPS FOR NEBULIZAT: 2 ml x 0.5 mg, 2
    mg. 500 μg-2,000 μg 2 x dly, adjust.
    dose as reqd. Child and adolesc. from
    4-16 yrs: 1,000 μg 2 x dly.
    Proph. severe asth., tmt. acute exacerb.
    asth. in adults, child. and adolesc. 4-16 yrs
    and over.

    Foster 200/6
    partial basket chart
    Multiple ingredients
    Foster 200/6

    Corticosteroid/Beta 2-Agonist. Beclometasone Dipropionate 200mcg/metered dose, Formoterol Fumarate 6mcg/metered dose.
    INHALER. (Pressurised sol. for inhal).:1×120 actuation.
    Adults 18 yrs. and above:
    Two inhalations twice dly.
    The max. dly. dose is 4 inhalat.
    Foster 200/6 should be used as mainten. therapy only. A lower strength (Foster 100/6) is available for mainten. and reliever ther.
    Indicated in the regular tmt. of asthma in adult. where use of a comb. product (inhaled corticosteroid and long-act. Β2-ag.) is appropriate:
    Pts. not adequate. control. with inhaled corticosteroids and 'as needed' inhaled rapid-acting Β2-agonist.
    Pts. already adequat. controlled on both inhaled corticosteroids and long-act. Β2-ag. C/I: Hypersens.


    Leukotriene Receptor Antagonist. Montelukast Sodium 4mg, 5mg.
    CHEWABLE TABS.:30. Adult. & adolesc. over 15 yrs. old: For tmt. of asthma and/or seasonal allerg. rhinitis, take 10 mg (two tabs.) ×1/d.Child. 6-14 yrs. old, for tmt. of asthma or season. allerg. rhinitis: One 5 mg ×1/d.
    Child. 2-5 yrs. old for tmt. of asthma or season. allerg. rhinitis: 4 mg ×1/d
    For tmt. of asthma, the drug should be taken once per day, in the eve.
     For tmt. of season. allergic rhinitis , the drug should be taken once per day.
    The tab.  should be chewed before swallow., regardless of meals.
    This drug is  not intended for babies & child. under 2 yrs. old. See lit.
    Indicated in adult and ped. pts. 2 yrs. of age and older for the prophylaxis and chron. tmt. of asthma, including preven. of daytime and nighttime sympt., the tmt. of aspirin-sensitive asthmatic pts., and the preven. of exercise-induced bronchoconstrict.

    The drug is effective alone or in comb. with other agents used in the mainten. tmt. of chron. asthma.

    This drug  and inhaled corticosteroids may be used concomit. with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintain. clinical stability.

    Indicated for the relief of sympt. of season. allerg. rhinitis in adults & ped. pts. 2 yrs. of age and older.
    C/I: Hypersens.

    Montelukast Teva 10 mg
    partial basket chart
    Montelukast Teva 10 mg

    Leukotriene Receptor Antagonist. Montelukast Sodium 10 mg.
    TABS: 28 x 10 mg. Asthma, season.
    allerg., rhinit: 1 tab dly in even. Season.
    allerg. rhinit: Individual. Asthma,
    season. allerg., rhinit: Adults, > 15 yrs:
    1 x 10 mg dly.
    Proph./chron. tmt asthma includ. day/
    night sympts., aspirin sens., excerciseinduced
    bronchoconstrict. Alone or in
    comb. other agents maint. tmt chron.
    asthma, inhaled coricosteroids used
    concom. with additive effect to control
    asthma/reduced inhaled corticosteroid
    dose while maint. clin. stabil.
    C/I: Hypersens. See lit.

    Other therapeutic systems under Respiratory System